Efficacy and Safety of Viaskin Peanut in Children With Immunoglobulin E (IgE)-Mediated Peanut Allergy
Completed · Phase 3 · Has a placebo group
Conditions studied: Peanut Allergy
In brief
The PEPITES study evaluates the efficacy and safety of Viaskin Peanut 250 µg peanut protein to induce desensitization to peanut in peanut-allergic children 4 through 11 years of age after a 12-month treatment by epicutaneous immunotherapy (EPIT).
Key facts
- Study ID
- NCT02636699
- Run by
- DBV Technologies
- People needed
- 500
- Starts
- 2015-12-01
- Expected to finish
- 2017-08-18
- Last updated by the study team
- 2025-06-18
Who can join
Age: 4 and older, up to 11. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Arkansas Children's Hospital — Little Rock, Arkansas, United States
- University of California, Rady Children's Hospital — San Diego, California, United States
- Stanford University School of Medicine — Stanford, California, United States
- Children's Hospital Colorado — Aurora, Colorado, United States
- National Jewish Health — Denver, Colorado, United States
- Ann & Robert H. Lurie Children's Hospital of Chicago — Chicago, Illinois, United States
- Johns Hopkins Hospital — Baltimore, Maryland, United States
- Massachusetts General Hospital — Boston, Massachusetts, United States
- Boston Childrens' Hospital — Boston, Massachusetts, United States
- Jaffe Food Allergy Institute — New York, New York, United States
- The University of North Carolina - Chapell Hill — Chapel Hill, North Carolina, United States
- Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio, United States
- Children's Hospital of Philadelphia — Philadelphia, Pennsylvania, United States
- Children's Hospital of Pittsburgh — Pittsburgh, Pennsylvania, United States
- Children's Medical Center of Dallas — Dallas, Texas, United States
- Baylor College of Medicine - Texas Children's Hospital — Houston, Texas, United States
- ASTHMA, Inc. — Seattle, Washington, United States
- Allergy Medical — Brisbane, Australia
- Princess Margaret Hospital for Children — Perth, Australia
- Children's Hospital Westmead — Sydney, Australia
- British Columbia Children's Hospital — Vancouver, British Columbia, Canada
- Cheema Research Inc. — Mississauga, Ontario, Canada
- Ottawa Allergy Asthma Research Institute — Ottawa, Ontario, Canada
- Gordon Sussman Clinical Research Inc. — Toronto, Ontario, Canada
- CHUM & CHU Sainte-Justine — Montreal, Quebec, Canada
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.